Category Archives: Off Patent

State slow to switch to cheaper off-patent drugs, forum hears

Source: Irish Times 17th April, 2019   Health service could save €50m by using biosimilar medicines, says Michael Barry Prof Michael Barry has told a conference the pricing structures of pharmaceutical companies are unsustainable. Photograph: PA Wire Just six patients … Continue reading

Posted in Access to Medicins, Biologics/Biosimilars, Drug prices, Off Patent, orphan drug | Leave a comment

US FDA publishes list of off-patent, off-exclusivity branded drugs without approved generics

Silver Spring, Maryland,  Pharmabiz | June 29, 2017 Thursday, June 29, 2017 The US Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency … Continue reading

Posted in Generic competition, Off Patent, Uncategorized | Leave a comment